We observed in the TCGA portal that SMAD4 was decreased in colon adenocarcinoma (COAD, upper) and breast cancer (BRCA, lower) samples compared to normal samples (Fig. 2A). This evidence concerns the gene SMAD4 and colon adenocarcinoma.